Celgene Corporation

Venture Capital

Global biopharmaceutical company focused on cancer and immunology drugs; acquired by Bristol-Myers Squibb in 2019. Made strategic biotech venture investments.

Summit, United States · 11+ investments · 8 portfolio companies

Early Stage
Growth
Late Stage
Biotech
Oncology
Headquarters
Summit, United States
Founded
1986
Portfolio Companies
8
Total Investments
11
Last Investment
Mar 2021
Geographic Focus
United States

Investment Thesis

Strategic co-investments and partnerships in oncology, immunology, and CRISPR therapeutics to complement internal drug development pipeline.

Celgene Corporation is a Venture Capital firm based in Summit, United States. It has made 11 investments, including PRESAGE BIOSCIENCES, INC., Sutro Biopharma and SYNVITROBIO, INC.. Focus areas include Biotech and Oncology.

Portfolio8

Co-investors24

Sign up to view co-investors

24 co-investors across 25 shared portfolio companies — who they back alongside, and how often they lead.

Venture Capital ×18 · Corporate VC ×3 · Private Equity ×3 · 29 shared rounds

Investment History

Sign up to view investment history

Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.

Your firm? Embed this profile

Add the live badge to your site — it stays current as your portfolio data updates.

Celgene Corporation on Indexed.vc
<a href="https://indexed.vc/investors/celgene-corporation"><img src="https://indexed.vc/api/badge/investor/celgene-corporation" alt="Celgene Corporation on Indexed.vc" width="260" height="76" /></a>